The high proportion of stereotyped BCR major subsets (4, 5), the significantly biased BCR gene usage compared with the normal repertoire (26), and the remarkable effect of BTKs (27, 28) in CLL patients offer support for the theory that BCR signaling is involved in the tumorigenesis and development of CLL. Here, BCR is linked to B-cell chronic lymphocytic leukemia.